跳至主要内容
临床试验/NCT04887623
NCT04887623招募中不适用

Dynamics of Nucleocapsid Antigen Serum Levels and Other Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients - a Pilot Study

University Hospital Hradec Kralove1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Prediction of severity of lung dysfunction based on initial interleukin-6 serum levels

研究概览

简要总结

Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load.

Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load.

In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.

详细描述

In this pilot study, 30 consecutive COVID-19 patients requiring admission to the hospital due to a moderate and severe COVID-19 infection will be included into an observational study.

Following parameters will be recorded: age, sex, weight, height, comorbidities, smoking habit,spiritus and drug intake history, length of COVID-19 symptoms, clinical and laboratory parameters, the use of different COVID-19 intervention (remdesivir, convalescent plasma, monoclonal antibodies, corticosteroids, tocilizumab and other medication), used initial and maximal organ support during the stay and outcome of the stay in the hospital and 28th and 90th day, laboratory markers of severity of infection - serum and tracheal aspirate (in ventilated patients) levels of nucleocapsid antigen,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) viremia and quantity in tracheal aspirates (in ventilated patients), makers of inflammatory response (C- reactive proteins, Interleukin 6, procalcitonin, ferritin) and selected other biochemical values (blood count, D-dimers, flow cytometry).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SARS CoV2 positive test within last 14 day
  • bilateral infiltrates on chest X.ray or CT
  • need for oxygen to keep pulse oximetry saturation above 92% or other respiratory support measures (HFNO, non-invasive ventilation or invasive ventilation)

排除标准

  • known history of intersticial lung disease
  • known history of congestive heart failure

结局指标

主要结局

Prediction of severity of lung dysfunction based on initial interleukin-6 serum levels

时间窗: Admission

Correlation between baseline interleukin -6 serum levels and Ordinal Scale for Clinical Improvement

Prediction of severity of lung dysfunction based on initial nucleocapsid antigen serum levels

时间窗: Admission

Correlation between baseline nucleocapsid serum levels and the Ordinal Scale for Clinical Improvement

Prediction of severity of lung dysfunction based on

时间窗: Admission

Correlation between baseline CRP serum levels and Ordinal Scale for Clinical Improvement

次要结局

  • Effect of age on persistence of tracheal viral load assessed using tracheal aspirate semiquantitative PCR(up to 28 days)
  • Effect of age on viral load assesed using nucleocapsid antigen serum levels(up to 28 days)
  • Effect of comorbidities on persistence of tracheal viral load assessed using tracheal aspirate semiquantitative PCR(up to 28 days)
  • Effect of the remdesivir on the nucleocapsid antigen serum levels(up to 28 days)
  • Tracheal viral load quantification using tracheal nucleocapsid antigen(up to 28 days)
  • Effect of the dose of corticosteroids on the nucleocapsid antigen serum levels(up to 28 days)
  • Effect of comorbidities on viral load assessed using nucleocapsid antigen serum levels(up to 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dostalova Vlasta, MD, PhD

principal investigator

University Hospital Hradec Kralove

研究点 (1)

Loading locations...

相似试验